title: Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!
authors.forename: Gavin M
authors.initials: GM
authors.lastname: Marx
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Steer
authors.forename: Peter
authors.initials: P
authors.lastname: Harper
authors.forename: Nick
authors.initials: N
authors.lastname: Pavlakis
authors.forename: Olivier
authors.initials: O
authors.lastname: Rixe
authors.forename: David
authors.initials: D
authors.lastname: Khayat
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D004338:Drug Combinations; D006801:Humans; D007211:Indoles / Q000009:adverse effects; D011758:Pyrroles / Q000009:adverse effects; D000093542:Gemcitabine
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D004338:Drug Combinations; D007211:Indoles; D011758:Pyrroles; D003841:Deoxycytidine; C116890:Semaxinib; D002945:Cisplatin; D000093542:Gemcitabine